Auto-Injectors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The auto-injectors market is segmented by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User, and Geography

Market Snapshot

AutoInjectors Market_Image 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 20.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Global Auto-Injectors market is expected to witness a CAGR of 20.7% during the forecast period. Certain factors that are driving the market growth include increasing demand for the convenience of patients, rising incidence of chronic and lifestyle diseases, and technological advancements.

The use of auto-injector has brought many benefits for both the patient and healthcare professional. It has simplified self-administration, reduced anxiety, improved safety, and improved compliance. For instance, most of the currently available disease-modifying therapies available in the market for the treatment of multiple sclerosis are administered through injection. This has always been considered as a source of fear for a large number of patients and a considerable cause of non-adherence to treatment. Autoinjectors can address this issue by ensuring that the injection is made at the accurate depth and can distinctly improve the comfort and tolerability of administration when compared to manual syringes. Data from various clinical trials support the use of autoinjectors presenting that they improve adherence and the smaller gauge needles significantly reduce injection discomfort.

Scope of the Report

Auto-Injector refers to a syringe which contains a spring-loaded needle generally with a preloaded dose of medication. Upon being forced against the body with a piercing motion, the device gets activated and administers a calculated dose of medication. Autoinjectors are usually used for self-administration of epinephrine (in order to mitigate anaphylaxis); by migraine sufferers who want to achieve quick relief of headache; or even by military as well as emergency services workers in order to combat the effects of nerve agents.

Application
Rheumatoid Arthritis
Multiple Sclerosis
Anaphylaxis
Others (Cardiovascular Diseases, Diabetes, Migraines, Psoriasis, and Anemia)
Type
Disposable Autoinjectors
Reusable Autoinjectors
End User
Home Care Settings
Hospital & Clinics
Others
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Rheumatoid Arthritis is Expected to Hold Significant Market Share in the Application Segment

Rheumatoid arthritis (RA) is a chronic autoimmune disorder in which the joints are attacked by the body’s immune system and inflammation of the synovium is created, causing swelling and pain in and around the joints. The RA Organisation, US, states that the disease affects over 1.3 million Americans and as much as 1% of the worldwide population (as of 2018). 

According to several recent studies, majority of the patients with rheumatoid arthritis who used an autoinjector for the treatment were observed to be comfortable using the device and even had better outcomes than those who had someone else administer injections.

Arthritis cases-2015-2040-CDC.png

North America Dominates the Market and Expected to do Same in the Forecasted Period

Several epinephrine auto-injectors are now available in the region. There are generic versions as well. Each contains the drug epinephrine. But, each device possesses its own unique set of instructions for use. Understanding the differences is essential so that one can get the device one wants and knows how to properly use it. In the region, children with severe allergies now have access to a new generic version of EpiPen and EpiPen Jr. Epinephrine auto-injectors. The US Food and Drug Administration (FDA) granted approval to Teva Pharmaceutical Industries Ltd., in 2018, to market the generics in 0.3 milligrams (mg) and 0.15 mg strengths.

Auto-Injectors Market - Growth Rate by Region

Competitive Landscape

The global Auto-Injectors market is highly competitive and consists of a number of major players. Companies like Abbvie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, Ypsomed, among others, hold the substantial market share in the Auto-Injectors market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Convenience of Patients

      2. 4.2.2 Rising Incidence of Chronic and Lifestyle Diseases

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Preference for Alternative Drug Delivery Modes

      2. 4.3.2 Regulatory Hurdles

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Application

      1. 5.1.1 Rheumatoid Arthritis

      2. 5.1.2 Multiple Sclerosis

      3. 5.1.3 Anaphylaxis

      4. 5.1.4 Others (Cardiovascular Diseases, Diabetes, Migraines, Psoriasis, and Anemia)

    2. 5.2 Type

      1. 5.2.1 Disposable Autoinjectors

      2. 5.2.2 Reusable Autoinjectors

    3. 5.3 End User

      1. 5.3.1 Home Care Settings

      2. 5.3.2 Hospital & Clinics

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 US

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 UK

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbvie

      2. 6.1.2 Amgen

      3. 6.1.3 AstraZeneca

      4. 6.1.4 Bayer

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Biogen

      7. 6.1.7 Eli Lilly

      8. 6.1.8 Novartis

      9. 6.1.9 Teva Pharmaceuticals

      10. 6.1.10 Ypsomed

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Auto-Injectors Market market is studied from 2018 - 2026.

The Auto-Injectors Market is growing at a CAGR of 20.7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Ypsomed, Abbvie, Amgen, Teva Pharmaceuticals, Biogen are the major companies operating in Auto-Injectors Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!